Hong Kong

Loading...

HKD overview

PairLatest rateToday's change1 year change
HKDGBP0.0953
GBP
0.000001 / 0.00%-0.0002 / -0.17%
Today
0.0924Jan 27 20260.0989Nov 04 2025
HKDEUR0.1111
EUR
-0.00007 / -0.06%0.0016 / 1.45%
Today
0.1061Jan 27 20260.1126Jun 24 2026
HKDUSD0.1275
USD
-0.000002 / 0.00%-0.0012 / -0.91%
Today
0.1274Aug 14 20260.1288Sep 22 2025
HKDJPY20.05
JPY
-0.0112 / -0.06%1.01 / 5.32%
Today
18.83Oct 01 202520.91Jul 23 2026
HKDAUD0.179
AUD
0.00 / 0.00%-0.0161 / -8.25%
Today
0.1753May 06 20260.20Nov 21 2025
HKDCAD0.1788
CAD
0.00 / 0.00%0.0016 / 0.87%
Today
0.1727Feb 11 20260.1819Nov 06 2025
HKDCNY0.8533
CNY
-0.00001 / 0.00%-0.0619 / -6.76%
Today
0.8532Sep 21 20260.9187Oct 14 2025
HKDCHF0.1047
CHF
0.0001 / 0.10%0.0024 / 2.30%
Today
0.0975Jan 27 20260.1054Sep 16 2026

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Hong Kong in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the Hang Seng with the highest percent gain over one day.
ListingLastChangeVolume
Sino Biopharmaceutical Limited1177:HKG5.92
HKD
+0.45
+8.23%
150.19m
CSPC PHARMACEUTICAL GROUP LIMITED1093:HKG9.61
HKD
+0.675
+7.56%
117.02m
Innovent Biologics, Inc.1801:HKG102.40
HKD
+5.80
+6.00%
21.58m
WuXi Biologics (Cayman) Inc.2269:HKG53.00
HKD
+2.65
+5.26%
38.60m
Xiaomi Corporation1810:HKG27.58
HKD
+1.18
+4.47%
137.70m
WuXi AppTec Co., Ltd.2359:HKG208.00
HKD
+8.00
+4.00%
4.73m
Hansoh Pharmaceutical Group Company Limited3692:HKG35.56
HKD
+1.26
+3.67%
11.89m
Alibaba Group Holding Limited9988:HKG112.60
HKD
+3.30
+3.02%
54.73m
Tencent Holdings Limited700:HKG430.00
HKD
+11.00
+2.63%
19.67m
Sun Hung Kai Properties Limited16:HKG110.50
HKD
+2.80
+2.60%
4.50m
Data delayed at least 15 minutes, as of Sep 21 2026 09:08 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.